Rofelodine

This classification denotes an antidepressant agent with the molecular formula C13H14N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 146D7G2I94, chemically known as 2,6,7,8-tetrahydro-7-phenylpyrrolo(1,2-a)pyrimidin-4(3h)-one but generally known as rofelodine, which bears US NIH Compound Identifier 71152. European Medicines Agency schedules Rofelodine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10356MIG. The term ROFELODINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). ROFELODINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule rofelodine under HS 29335995 and SITC 51576. As of Q4 2014, ROFELODINE remains the US FDA Preferred Term for this commodity. Rofelodine bears US NLM identifiers UMLS ID C2699092 and NCI Concept Code C75176. SMILES: O=C1N2CC(CC2=NCC1)c1ccccc1.